Oorsprong van het eerstegraads netwerk van Karen Liu
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Quadriga BioSciences, Inc.
Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015.
3
| Private Company | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Karen Liu via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
VIVUS, INC. | Pharmaceuticals: Major | President | |
XOMA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Founder | |
ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Alavita Pharmaceuticals, Inc.
Alavita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alavita Pharmaceuticals, Inc. develops pharmaceutical therapeutic products. The company was founded on October 9, 2007 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Protein Metrics, Inc.
Protein Metrics, Inc. Information Technology ServicesTechnology Services Part of Insightful Science Holdings LLC, Protein Metrics, Inc. is a company that specializes in protein characterization. The company is based in Cupertino, CA at the crossroads of computing and biotechnology. The company's vendor-neutral software enables scientists to quickly identify and report protein sequences and variations from the expected form using data generated on analytical instruments like mass spectrometers. The company was founded by Yong Kil, Marshall Bern, Chris Becker, and Eric Carlson has been the CEO of the company since 2014. Protein Metrics was acquired by Insightful Science Holdings LLC on December 21, 2021. | Information Technology Services | Director/Board Member | |
Affymax Research Institute
Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Miscellaneous Commercial Services | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Oxonica Ltd.
Oxonica Ltd. Miscellaneous Commercial ServicesCommercial Services Oxonica Ltd. is an advanced materials business, which engages in licensing of patents related to nanomaterials. The company was founded in 1999 and is headquartered in Birmingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
XENOPORT, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Bucknell University | College/University | Undergraduate Degree | |
Rutgers State University of New Jersey | College/University | Doctorate Degree | |
Santa Clara University | College/University | Masters Business Admin | |
University of California, Berkeley | College/University | Undergraduate Degree | |
University of California, Santa Cruz | College/University | Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree | |
SurroMed, Inc.
SurroMed, Inc. Miscellaneous Commercial ServicesCommercial Services SurroMed, Inc. provides pharmaceutical research. It focuses on discovering & applying biomarkers to improve the drug discovery and development process and enable the precise diagnosis and personalized treatment of disease. The company's research process yields biological markers and information that enable accelerated, cost-efficient discovery and development of new therapeutic products, as well as development of diagnostic tests for early disease detection, disease staging, patient stratification, guiding and monitoring therapy. SurroMed was founded in 1997 and is located in Menlo Park, CA. | Miscellaneous Commercial Services | Chief Executive Officer | |
SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Maverix Biomics, Inc.
Maverix Biomics, Inc. Miscellaneous Commercial ServicesCommercial Services Maverix Biomics, Inc. provides cloud-based platform to manage, analyze and visualize genomic data. It also builds communities of discovery and place its data in context with the latest public data from the full spectrum of life, including human, plant, animal or microbial organisms. The company was founded by David Mandelkern, Todd Michael Johnson Lowe and Patricia Pak Lee Chan in 2010 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Chairman | |
Technogen Associates LP | Corporate Officer/Principal | ||
Okava Pharmaceuticals, Inc.
Okava Pharmaceuticals, Inc. BiotechnologyHealth Technology Okava Pharmaceuticals, Inc. is an American clinical stage biotechnology company. | Biotechnology | Director/Board Member | |
JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Medikine, Inc.
Medikine, Inc. Pharmaceuticals: MajorHealth Technology Medikine, Inc. is a privately held biopharmaceutical company located in an undisclosed location. The American company's mission is to transform the discovery of oncology, autoimmune disorder, and infectious disease therapeutics by employing a versatile drug discovery platform that generates modular "peptikines." These peptikines are peptide mimetics of cytokines that are smaller in molecular size than, and structurally unrelated to, the natural cytokines they emulate. Medikine's lead candidate, mdk-703, is currently in a phase 1 clinical trial in healthy volunteers. Ronald W. Barrett has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Executive Officer | |
APEXIGEN, INC. | Biotechnology | Director/Board Member | |
Rapafusyn Pharmaceuticals
Rapafusyn Pharmaceuticals Industrial SpecialtiesProcess Industries Rapafusyn Research & Development, Inc. develops non-degrading molecular glues. The company is based in Baltimore, MD. The CEO of the company is Sean X. Hu. | Industrial Specialties | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 31 |
Verenigd Koninkrijk | 2 |
Sectoraal
Health Technology | 18 |
Consumer Services | 7 |
Commercial Services | 6 |
Technology Services | 2 |
Process Industries | 2 |
Operationeel
Director/Board Member | 18 |
Independent Dir/Board Member | 7 |
Corporate Officer/Principal | 6 |
Chief Executive Officer | 6 |
Chairman | 5 |
Sterkste connecties
Insiders | |
---|---|
Gordon Ringold | 20 |
Ronald Barrett | 9 |
Peter Y. Tam | 6 |